Main Article Content


The chemotherapeutic efficacy of diminazene aceturate (DA) and isometamidium chloride (IMC) were compared in dogs experimentally infected with Trypanosoma brucei. Twenty Nigerian local breeds of dogs were used for the study. They were divided into four groups of five dogs each. Dogs in group I served as uninfected untreated control, group II was infected untreated, while groups III and IV were the infected treated with DA and IMC respectively. Administration of DA and IMC effectively cleared the parasites from the blood stream of the treated dogs. However, the infection subsequently relapsed at days 28 and 49 post treatment (pt) in DA and IMC treated groups, respectively. The red cell parameters (PCV, HB, and RBC) decreased significantly (P<0.05) following infection. They were significantly (P < 0.05) higher in IMC treated group than the DA treated group comparable with the control. The infected groups had elevated total white blood cell counts. However, the DA treated, and IMC treated groups did not show any significant (P> 0.05) difference when compared together with the control. The mean activities of SAP, AST, and ALT increased significantly (P<0.05) in the infected groups compared with the control. The mean blood urea nitrogen (BUN) increased significantly (P<0.05) on days 21 and 28 post infection (pi) in the infected untreated group and IMC treated groups. The mean creatinine(CRT) was significantly (P<0.05) higher in all the infected groups on day 14 pi compared to the control. From day 35 pi the mean BUN and CRT levels returned to normal values. It was thus concluded from this study that IMC exhibited more chemotherapeutic therapeutic activity over DA, as evidenced from the result of relapsed infections post treatment and haematological changes. However, the serum biochemical parameters were significantly altered in both DA and IMC treated groups compared to the control.


Chemotherapy; Diminazene aceturate; Dogs; Isometamidium chloride; Trypanosoma brucei.

Article Details

How to Cite
Akpa, P. O., Ukwueze, C. S., Nnaji, T. O., & Anene, B. M. (2023). Comparison of the Therapeutic Efficacy of Diminazene Aceturate and ‎Isometamidium Chloride in Local Dogs Experimentally Infected ‎with Trypanosoma brucei. Sahel Journal of Veterinary Sciences, 20(4), 1-7.


  1. Abenga, J. N., Enwezor, F. N. C., Lawani, F. A. G., ‎Ezebuiro, C., Sule, J. and David, K. M. (2002). ‎Prevalence of trypanosomiasis in trade cattle at ‎slaughter in Kaduna, Nigeria. Niger. J. Parasitol. ‎‎23(1): 107–10‎
  2. Abenga., J. N. and Vuza, D. (2005). About factors that ‎determine trypanotolerance and prospects for ‎increasing resistance against trypanosomosis. ‎Afr. J. Biotechnol. 4(13) :1563-1567, December ‎‎2005 Available online at ‎
  3. Amole, B. O., Clarkson. J. R. and Shear, H. L. (1982). ‎Pathogenesis of anaemia in Trypanosoma ‎brucei brucei infected mice. Infect. Immun. 36(3), ‎‎1060- 1068. ‎‎‎‎1068.1982‎
  4. Andrianarivo, A. G., Muiya,P., Opollo, M. and Logan-‎Henry, L. L. (1995). Trypanosoma congolense: ‎comparative effects of a primary infection on ‎bone marrow progenitor cells from N’dama and ‎Boran cattle. Exp. Parasitol,80, 407-‎‎418.‎
  5. Anene, B. M. and Omamegbe, J. O. (1987). Common ‎diseases of dogs in Nigeria. Zariya Vet.4, 11- 18. ‎
  6. Anene, B. M., Chukwu, C. C. and Anika, S. M. (1989). ‎Immunosuppression of humoral immune ‎response in canine trypanosomosis. Microbios ‎Let. 40:37-46.‎
  7. Aquinos, L. P. C. T., Machado, R. Z., Allesi, A. C., ‎Santana, A. E., Castro, M. B. and Marques, L. C. ‎‎(2002). Hematological, biochemical and ‎anatomopathological aspects of experimental ‎infection with Trypanosoma evansi in dogs. Arq. ‎Bras. Med. Vet.Zootec. 54(1), 8-‎‎18.‎‎09352002000100002
  8. Barr, S. C., Gossett, K. A. and Klei, T. R. (1991). Clinical, ‎clinico- pathologic, observation, and ‎parasitoloogic observation of trypanosomiasis in ‎dogs infected with North American ‎Trypanosoma cruzi isolates.Am. J. Vet. Res. ‎‎56(6): 954-960.PMID: 1909105.‎
  9. Barrett, M. P. (2001). A possible veterinary link to drug ‎resistance in human African trypanosomiasis. ‎Lancet, 358: 603-604.‎
  10. Barrett, M. P., Burchmore, R. J. S., Stich, A., Lazzari, J. O., ‎Frasch, A. C. and Cazzulo, J. J. (2003). The ‎trypanosomiases. Lancet, 362: 1469-1480. DOI: ‎‎10.1016/S0140-6736(03)14694-6‎
  11. Barrett, M. P., Coombs, G. H. and Mottram, J. C. (2004). ‎Future Prospects in Chemotherapy for ‎Trypanosomiasis. In: The Trypanosomiasis (I ‎Maudlin, PH Holmes, MA Miles, editors), CAB ‎International. Wallingford, UK. Pp 445- 460.doi: ‎‎10.1016/S0140-6736(01)05817-‎
  12. Coles, E.H. (1986) Veterinary Clinical Pathology. 4th ‎Edition, W.B. Sounders Company, Philadelphia, ‎‎220-239.‎
  13. CVBD, (2010). Canine Vector Born Diseases. ‎Trypanosomosis. 4th Internal Symposium.‎
  14. Delespaux, V. and de Koning, H. P. (2007). Drugs and ‎drug resistance in African trypanosomiasis. Drug ‎Resist. Updat. 10, 30–50. ‎‎
  15. Desquesnes, M., Holzmuller, P., Lai, D. H., Dargentes, A., ‎Lun, Z. R. andJittaplapong, S. (2013). ‎Trypanosoma evansi and surra: A review and ‎perspectives on origin, history, distribution, ‎taxanomy, morphology, hosts and pathogenic ‎effects. Biomed. Res. Int. 10, ‎‎
  16. Duncan, O. D. (1966). Path analysis: sociological ‎examples. Am. J.Sociol, 72: 1-16.‎
  17. Espuelas, S., Plano, D., Nguewa, P., Font, M., Palop, J. A. ‎and Irache, J. M. (2012). Innovative lead ‎compounds and formulation strategies as newer ‎kinetoplast therapies. Curr. Med. Chem. 19(25): ‎‎4259–4288. ‎doi: 10.2174/092986712802884222‎
  18. Franciscato, C., Lopes, S. T. A., Teixeira,M. M. G., ‎Monteiro, S. G., Waolkmer, P. and Garmatz, B. ‎C. (2007). Cao natural ‎menteinfectadoporTrypanosoma evansiem ‎Santa Maria, R. S, Brazil. CiĕRur. 37(1), 288-‎‎291.‎‎84782007000100049‎
  19. Geerts, S., Holmes, P. H., Eisler M. C. and Diall O. ‎‎(2001). African bovine trypanosomiasis: the ‎problem of drug resistance. Trends Parasitol. 17, ‎‎25–28.doi: 10.1016/s1471-4922(00)01827-4‎
  20. Giordani, F., Morrison, L. J., Rowan, T. G., De Koning, H. ‎P. and Barrett, M. P. (2016). The animal ‎trypanosomiases and their chemotherapy: a ‎review. Parasitol, 143(14), 1862–89. ‎doi:10.1017/S0031182016001268‎
  21. Herbert, W. J. and Lumsden,W. H. R. (1976). ‎Trypanosoma brucei: A rapid matching method ‎for estimating the host’s ‎parasitaemia.ExpParasitol, 40, 427-‎‎428.‎‎4894(76)90110-7‎
  22. Holmes, P. H., Eisler M. C. and Geerts S. (2004). Current ‎chemotherapy of animal trypanosomiasis ‎In The Trypanosomiases (ed. Maudlin I., ‎Holmes P. H. and Miles M. A.), pp. 431–444. ‎CAB International, Wallingford, UK.‎
  23. Jennings, F. W., Urquhart, G. M., Murray, P. K. andMiller, ‎B. M. (1980). Berenil and Nitromidazole ‎combinations in the treatment of Trypanosoma ‎brucei infections with Central Nervous System ‎involvement. Int. J.Parasitol,10, 27- ‎‎33.‎‎7519(80)90060-0‎
  24. Jones, T. W. and Davila, A. M. R. (2001). Trypanosoma ‎vivax-out of Africa (Review). Trends Parasitol. ‎‎17: 99-101.doi: 10.1016/s1471-4922(00)01777-‎‎3‎
  25. Mario, L., De La Rue, R. A. S. and Geraldo, A. D. C. ‎‎(1997). Coagulopathy in dogs infected with ‎Trypanosoma evansi. J. Clin. Microbiol. 23: 45- ‎‎52.‎‎07201997000300005‎
  26. Nwoha, R. I. O. and Anene, B. M. (2011). Changes in ‎pack cell volume and haemoglobin ‎concentration in dogs with single and conjunct ‎experimental infections of T. brucei and A. ‎caninum. J Anim Sci,32(2), 151-‎‎158.‎
  27. Nwoha,R. I. O., Eze, I. O. and Anene B. M. (2013). Serum ‎biochemical and liver enzymes changes in dogs ‎with single and conjunct experimental infections ‎of Trypanosoma brucei and Ancylostoma ‎caninum. Afr J Biotechnol,12(6), 618-624. DOI: ‎‎10.5897/AJB10.2594‎
  28. Obi, C. F., Okpala, M. I., Ezeh, I. O., Onyeabor, ‎A. and Ezeokonkwo, R. C. (2021).Drug-resistant ‎trypanosome isolates populations in dogs in ‎Enugu North Senatorial Zone, ‎SoutheasternNigeria. Parasitol. Res. 121(1):423-‎‎431DOI: 10.1007/s00436-021-07362-x
  29. Omeke, B. C. O. andUgwu, D. O. (1991). Pig ‎trypanosomosis: comparative anaemia and ‎histopathology of lymphoid organs. Rev. Elev. ‎Méd. Vét. Pays.Trop,44(3):267-72. PMID: ‎‎1824133.‎
  30. Onyeyili, P. A. and Anika, S. M. (1989). Chemotherapy ‎of Trypanosoma brucei brucei infections: use of ‎DFMO, diminazene aceturate alone and in ‎combination. J. Small Anim. Pract,30, 505-‎‎510.‎‎5827.1989.tb01621.x‎
  31. Onyeyili, P. A. and Anika, S. M. (1991). Diminazene ‎aceturate residues in the tissues of healthy ‎Trypanosoma congolense and Trypanosoma ‎brucei brucei infected dogs. Br. Vet. J. 147: 155-‎‎161.‎‎1935(91)90106-W
  32. Sewell, M. M. H. and Brocelesby, D. W. (1990). ‎Handbook on animal diseases in the tropics ‎‎(London: Bailere Tindall, fourth edition). Pp. ‎‎205-217‎
  33. Sivajothi, S., Rayulu, V. C. and Sudhakara Reddy, B. ‎‎(2013). Haematological and biochemical ‎changes in experimental Trypanosoma ‎evansi infection in rabbits. J.Parasit. Dis. 239(2), ‎‎216–220.DOI: 10.1007/s12639-013-0321-6‎
  34. Swallow, B. M. (2000). Impacts of trypanosomosis in ‎african agriculture, programme against ‎africantrypanosomosis technical and scientific ‎series. Food Agriculture Organization. 2:45-46‎